Silo Pharma (SILO) Asset Utilization Ratio (2020 - 2026)
Silo Pharma (SILO) posted Asset Utilization Ratio of 0.01 for Q1 2026, down 4.33% sequentially from 0.01 in Q4 2025, and down 8.97% YoY from 0.01 in Q1 2025.
Silo Pharma (SILO) Asset Utilization Ratio (2020 - 2026) Analysis & Trends
Silo Pharma has reported Asset Utilization Ratio for 7 years, with the latest figure at 0.01 in Q1 2026.
- Quarterly Asset Utilization Ratio fell 8.97% year-over-year to 0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01 (down 8.97% YoY) and the FY2025 annual result came in at 0.01, up 0.94% from the prior year.
- Asset Utilization Ratio retreated to 0.01 in Q1 2026 per SILO's latest filing, from 0.01 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.02 in Q2 2022 and troughed at 0.01 in Q1 2023.
- A 5-year average of 0.01 and a median of 0.01 in 2024 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio tumbled 59.15% in 2023, then surged 54.33% in 2024.
- Over 5 years, Asset Utilization Ratio stood at 0.01 in 2022, then fell by 12.9% to 0.01 in 2023, then climbed by 4.72% to 0.01 in 2024, then grew by 14.22% to 0.01 in 2025, then slipped by 4.33% to 0.01 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.01, 0.01, and 0.01 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - | 0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01 |
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.02 |
| Jun 30, 2021 | 0.03 |
| Mar 31, 2021 | 0.03 |
| Dec 31, 2020 | 0.02 |